We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

4 hedge funds and large institutions have $11.4M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $7.12M → $11.4M (+$4.25M)

0% more funds holding

Funds holding: 4 → 4 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PF
Phoenix Financial
Israel
-$324K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$5.72M – – –
BI
2
BVF Inc
California
$5.26M – – –
PF
3
Phoenix Financial
Israel
$267K -$324K -3,705 -53%
Millennium Management
4
Millennium Management
New York
$129K – – –

PHXM Hedge Fund Activity: Q2 2020 in Review

4 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q2 2020, worth a combined $11.4M — up 60% from $7.12M a quarter earlier.

Fund positioning in PHXM was balanced in Q2 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Phoenix Financial, cutting an estimated $324K.

  • 4 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $11.4M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q2 2020, up 60% quarter-over-quarter.
  • 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q2 2020 and 0 closed out.
  • The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q2 2020 was Phoenix Financial, an estimated $324K sold.

Based on aggregated 13F filings for Q2 2020.